Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM

AbstractThe Italian College of Breast Radiologists by the Italian Society of Medical Radiology (SIRM) provides recommendations for breast care provision and procedural prioritization during COVID-19 pandemic, being aware that medical decisions must be currently taken balancing patient ’s individual and community safety: (1) patients having a scheduled or to-be-scheduled appointment for in-depth diagnostic breast imaging or needle biopsy should confirm the appointment or obtain a new one; (2) patients who have suspicious symptoms of breast cancer (in particular: new onset palpab le nodule; skin or nipple retraction; orange peel skin; unilateral secretion from the nipple) should request non-deferrable tests at radiology services; (3) asymptomatic women performing annual mammographic follow-up after breast cancer treatment should preferably schedule the appointment within 1  year and 3 months from the previous check, compatibly with the local organizational conditions; (4) asymptomatic women who have not responded to the invitation for screening mammography after the onset of the pandemic or have been informed of the suspension of the screening activity should schedule the check preferably within 3 months from the date of the not performed check, compatibly with local organizational conditions. The Italian College of Breast Radiologists by SIRM recommends precautions to protect both patients and healthcare workers (radiologists, radiographers, nurses, and re...
Source: La Radiologia Medica - Category: Radiology Source Type: research

Related Links:

For breast cancer, partial and total breast reconstruction reduce patient's sensation of mutilation, improving their quality of life. On the other hand, the pandemic of the COVID-19 resulted in the implementation of social distancing measures, with a negative effect on the management of different diseases. We read the article of Di Pace et al entitled “Breast reconstruction and the COVID-19 pandemic: A viewpoint1”. We agree that risk-reducing surgeries, contralateral operation and revisional procedures should be postponed.
Source: Journal of Plastic, Reconstructive and Aesthetic Surgery - Category: Cosmetic Surgery Authors: Tags: Correspondence and Communications Source Type: research
No abstract available
Source: Plastic and Reconstructive Surgery - Category: Cosmetic Surgery Tags: Viewpoints Source Type: research
This article summarizes the effect of the global pandemic – and efforts to curtail its spread – on both breast cancer care and on breast imaging pract ices including effects on patients, clinical workflow, education and research.
Source: Radiologic Clinics of North America - Category: Radiology Authors: Source Type: research
[Gastrointestinal symptoms revealing COVID-19 in Malian breast cancer patient undergoing chemotherapy]. Bull Cancer. 2020 Sep 21;: Authors: Sidibe FM, Bathily M, Diarra B, Kone AS, Diabate K, Konate M, Cisse HL, Guindo I, Kone AA, Kone J, Berthe D, Ouattara BZ, Fofana Y, Sidibe A, Akpa AA, Dembele JP, Toure BA, Diakite A, Diarra IM, Kone AC, Soumare MD, Minta D, Dao S, Toloba Y, Diallo DA, Sidibe S Abstract In this review, we report a case of a bone's metastatic breast cancer in Malian patient treated by chemotherapy in whom SRAS-COV-2's diagnosis was made 9days after the onset gastrointestinal s...
Source: Bulletin du Cancer - Category: Cancer & Oncology Authors: Tags: Bull Cancer Source Type: research
We report the results of a national survey on variations of breast reconstruction practices during the COVID-19 pandemic in France. More than 70% of surgeons relied on local multidisciplinary validation meetings to discuss intra-hospital constraints and the risk-benefit balance for each BR patient. Multidisciplinary validation appeared to be the most pertinent strategy to face the evolving nature of the pandemic.
Source: Journal of Plastic, Reconstructive and Aesthetic Surgery - Category: Cosmetic Surgery Authors: Tags: Correspondence and Communications Source Type: research
The pandemic infection due to the new COVID-19 (coronavirus disease 2019) has led to drastic changes in the delivery of standard of healthcare in the UK and worldwide by extension. The unprecedented nature of this virus has led to development of new pathways and new ways of delivery of care. UK government guidelines stipulates protection of those most at risk of severe illness from COVID-19 and suggest these vulnerable groups follow strict social distancing guidelines to mitigate the risk of acquiring the infection.
Source: Journal of Plastic, Reconstructive and Aesthetic Surgery - Category: Cosmetic Surgery Authors: Tags: Correspondence and Communications Source Type: research
Abstract The COVID-19 pandemic poses current and future challenges in the maintenance of surgical operating capacity. In the United Kingdom surgery has continued-in a reduced capacity-through the establishment of regional 'cancer hubs' using independent sector facilities to treat public healthcare patients. It is essential that these scarce operating facilities available are optimally utilized and that logistical challenges that result from remote operating away from the surgeon's primary hospital site are considered. These issues are best addressed through the application of currently available medical technology...
Source: Breast Cancer - Category: Cancer & Oncology Authors: Tags: Breast Cancer Source Type: research
Basel, 17 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that results from a number of studies across its broad oncology portfolio will be presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020, which will be held 19-21 September, 2020. Results include data from three phase III studies across the Tecentriq® (atezolizumab) triple-negative breast cancer (TNBC) programme. Central nervous system (CNS) efficacy data from integrated analyses of the pivotal phase II Rozlytrek® STARTRK-2, phase I STARTRK-1, and phase I ALKA-372-001 trials will be presented in addition to re...
Source: Roche Media News - Category: Pharmaceuticals Source Type: news
ConclusionsThis tool generates a clinically consistent, risk-stratified priority list of breast surgical procedures delayed by the COVID-19 pandemic. This systematic approach may facilitate surgical scheduling as conditions normalize.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
According to some estimates, the global digital health market is expected to exceed $504.4 billion by 2025; that’s a nearly six-fold increase from its $86.4 billion 2018 valuation. The COVID-19 pandemic has accelerated both the adoption of and the innovation in digital health and will propel this growth in the coming years. The current situation led to the widespread adoption of telemedicine; people are using digital health apps to stay physically and mentally healthy while indoors; governments are promoting contact tracing apps to limit the virus’ spread. This increased adoption of digital health solutions ...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: 3D Printing Artificial Intelligence Augmented Reality Biotechnology Digital Health Research E-Patients Future of Medicine Future of Pharma Genomics Health Sensors & Trackers Healthcare Design Nanotechnology Personalized Medicine Source Type: blogs
More News: Breast Cancer | Breast Needle Aspiration | Cancer | Cancer & Oncology | COVID-19 | Italy Health | Mammography | MRI Scan | Nurses | Nursing | Pandemics | Radiography | Radiology | Skin | Skin Biopsy | Ultrasound | Women